Oxford Sciences Innovation has contributed to a series B round for Evox Therapeutics, a spinout of University of Oxford that has also added GV as a shareholder.

Eight researchers from Cambridge have raised a $129m patient capital fund that has attracted limited partners including Aviva.

Legal & General has co-led a $20m series B round for Salary Finance, a financial wellbeing platform for employees.

GV has contributed to a series B round for Evox Therapeutics, a spinout of University of Oxford whose existing shareholders include Oxford Sciences Innovation.

Eight researchers from Cambridge have raised a $129m patient capital fund that has attracted limited partners including Aviva.

Rocket Internet-backed peer-to-peer lender Funding Circle plans to raise $385m in an initial public offering in which private investor Anders Povlsen is set to purchase a 10% stake.

Almi Invest and trade union Unionen have both returned with funding for Beactica, a drug discovery company based on Uppsala University research.